It’s no secret that big pharma is big business. Americans spend hundreds of billions on prescription medications every year, with that figure projected to keep growing. And now a new report shows that the top-selling brand-name prescription drugs in the U.S. earn more than $60 billion a year for their manufacturers, with the biggest money-maker topping $13 billion per year in sales on its own. [More]
crestor
Here’s How AstraZeneca Is Trying To Block Generic Crestor For 7 More Years
How long should a drug company be allowed to be the exclusive manufacturer and seller of their product? Crestor, a best-selling statin (cholesterol-lowering drug) that has enjoyed exclusivity for the last 12 years, is due to lose that protection today. AstraZeneca, the maker of Crestor, is fighting that decision, hoping to squeeze a little more time as the drug’s exclusive manufacturer before generics hit the market. [More]
FDA Adds Diabetes & Memory Loss Warnings To Statins
Widely used cholesterol-lowering statin drugs like Lipitor (atorvastatin), Crestor (rosuvastatin), Zocor (simvastatin), Simcor (simvastatin/niacin extended-release), Vytorin (simvastatin/ezetimibe) and many others will now have additional warnings on their packaging, according to an announcement from the Food & Drug Administration. [More]